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In the current model of the mammalian circadian
clock, PERIOD (PER) represses the activity of
the circadian transcription factors BMAL1 and
CLOCK, either independently or together with
CRYPTOCHROME (CRY). Here, we provide evidence
that PER has an entirely different function from that
reported previously, namely, that PER inhibits CRY-
mediated transcriptional repression through interfer-
ence with CRY recruitment into the BMAL1-CLOCK
complex. This indirect positive function of PER is
consistent with previous data from genetic analyses
using Per-deficient or mutant mice. Overall, our re-
sults support the hypothesis that PER plays different
roles in different circadian phases: an early phase in
which it suppresses CRY activity, and a later phase in
which it acts as a transcriptional repressor with CRY.
This buffering effect of PER on CRY might help to
prolong the period of rhythmic gene expression.
Additional studies are required to carefully examine
the promoter- and phase-specific roles of PER.INTRODUCTION
Circadian rhythms are essential biological processes that are
found in almost all organisms, ranging from bacteria tomammals
(Menaker et al., 1997; Young and Kay, 2001). The rhythmic cell-
autonomous expression of clock genes generates circadian
rhythms (Rosbash, 1998; Schibler and Sassone-Corsi, 2002).
In mammals, the most widely accepted theory for the rhythmic
expression of clock genes is that the expression of Per genes
is driven by the CLOCK (NPAS2)-BMAL1 transcription complex
(Gekakis et al., 1998). Subsequently, PER proteins, indepen-
dently or together with CRY, function to negatively regulate
this complex (Ko and Takahashi, 2006; Reppert and Weaver,
2001).
In vivo phenotypic approaches have limitations for elucidating
clock protein functions; therefore, it is essential to support them
by in vitro functional analyses. However, this approach has not1056 Cell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authorsbeen completely successful in the case of PER protein, for
several reasons. Per knockout mice exhibit severe circadian de-
fects (Bae et al., 2001; Cermakian et al., 2001; Zheng et al., 1999,
2001), but transcriptional activity assays have demonstrated that
the repressive effect of PER on transcription is much lower than
that of CRY, implying that in vitro functional analyses of PER
have not provided evidence to support the in vivo phenotypes.
In contrast to Cry-deficient mice, Per knockout mice show
reduced levels of Per and Cry expression, which contradicts
the general model in which PER proteins are transcriptional re-
pressors of Per and Cry (Bae et al., 2001; Zheng et al., 2001;
Zheng et al., 1999). These discrepancies may indicate that
PER has unknown functions. In fact, several previous reports
suggested that PER2 may have a positive effect on transcription
in a promoter-specific manner (Chappuis et al., 2013; Hampp
et al., 2008; Kaasik and Lee, 2004).
Here, we provide evidence that PER may inhibit CRY-medi-
ated transcriptional repression via the physical interaction of
PER with CRY, suggesting that PER functions as a buffer to
decelerate the transcriptional repression process. Subse-
quently, via a posttranslational modification of PER, such as
phosphorylation, the PER-CRY complex would gradually take
on an active role as a transcriptional repressor.
RESULTS
PER2 Induces Transcriptional Upregulation in a CRY-
Dependent Manner
We examined the transcriptional activity of Per2 in the pres-
ence of PER2 or CRY1 expression vectors to compare the
functional roles of PER and CRY in Per2 transcription (Fig-
ure 1A). Per2 is one of the clock genes and its transcription is
activated by the CLOCK (NPAS2)-BMAL1 complex (Akashi
et al., 2006; Travnickova-Bendova et al., 2002; Yoo et al.,
2005). As expected, a luciferase reporter assay revealed that
transfection of only a small amount of a CRY1 expression vec-
tor caused potent inhibition of the Per2-luc activity in a dose-
dependent manner. However, the introduction of an increasing
amount of PER2 resulted in a dose-dependent mild upregula-
tion of Per2 transcription. The upregulation levels were not
high (approximately 2-fold elevation) and the upregulation
became saturated with relatively low amounts of PER2. These
Figure 1. PER2 Counteracts CRY1 via a Physical Interaction
(A) Luciferase assay. Per2-luc represents the Per2 promoter-driven firefly luciferase gene. Data (Fluc/Rluc relative light unit [RLU]) show relative firefly luciferase
activity (Fluc RLU), which was normalized by Renilla luciferase activity (Rluc RLU). Data are represented as mean ± SE for triplicate samples. The numbers (under
the abscissa axis) indicate the amount of DNA transfected into NIH 3T3 cells.
(B) Luciferase assay. The indicated plasmids were transfected into wild-type and Cry-deficient MEFs (Cry1/Cry2 double knockout).
(C) Luciferase assay. Western blotting data show PER2 or PER2DCBD expression levels.
(D) Schematic representation of a deletion mutant of PER2 that lacked the CRY-binding domain, and luciferase assay data (NIH 3T3 cells).
(E–H) NIH 3T3 cells were transfected with the indicated expression vectors (time = 0). Immediately after transfection, BMAL1-CLOCK-activatedPer2 transcription
was monitored in real time using a cell-culture-based luminescent monitoring system in the presence of luciferin. In (E)–(H), a Lac repressor-expressing vector
was also introduced into cells, whereas in (F) and (H), an IPTG-inducible CRY1 expression vector was transfected simultaneously. Approximately 10 hr after
transfection, 2 mM IPTG was added to the culture media to induce CRY1. To normalize for the transfection efficiency, light emission immediately before the
addition of IPTG was set to one. Data are represented as mean ± SE for triplicate samples.observations may indicate that the PER-mediated upregulation
was due to an indirect effect, which was limited by an endog-
enous molecule(s).
How does the PER2 protein upregulate the Per2 promoter?
PER2-mediated weak activation may be associated with a
physical interaction with endogenous CRY, a potent transcrip-
tional inhibitor. PER2 interacts with CRY1 via its C-terminal
domain (Akashi et al., 2002). Therefore, PER-CRY complex
formationmight neutralize CRY-mediated transcriptional repres-
sion. To test this hypothesis, we generated mouse embryonic
fibroblasts (MEFs) carrying null mutations for the Cry1 and
Cry2 genes (Cry/), and compared PER2-mediated upregula-
tion in the presence and absence of endogenous CRY proteins.
The basal transcriptional activity of Per2 in the Cry/ MEFsCwas higher than that in the wild-type MEFs, which suggests
that endogenous CRY repressed Per2 transcription (Figure 1B,
left). Importantly, PER2 upregulated Per2 transcription in the
wild-type MEFs, but not in the Cry/ MEFs (Figure 1B, right).
These results strongly suggest that the interaction of PER2
with endogenous CRY is essential for PER2-mediated upregula-
tion. These data also support the hypothesis that PER2-medi-
ated mild upregulation is an indirect effect that results from the
neutralization of endogenous CRY. To further validate this
hypothesis, we used an expression construct of PER2 that
lacked the CRY-binding domain (PER2DCBD, lacking 1,068–
1,257). PER2DCBD did not upregulate Per2 transcription (Fig-
ure 1C). The deletion of the C-terminal region had little effect
on the PER2 protein levels.ell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authors 1057
PER2 Inhibits CRY1-Mediated Transcriptional
Repression
The ability of PER2 to inhibit CRY-mediated transcriptional
repression was verified. Interestingly, as shown in Figure 1D,
PER2 counteracted the CRY1-mediated potent inhibition of
Per2 transcription. The PER2-induced effect was detectable
at doses higher than those of the CRY1 expression plasmid,
and it increased in a dose-dependent manner. Importantly,
PER2DCBD did not induce any significant changes in the
CRY1-mediated potent inhibition of Per2 transcription, indi-
cating that the PER2-induced neutralizing effect is completely
dependent on the physical association with CRY1.
We constructed an isopropyl b-D-1-thiogalactopyranoside
(IPTG)-inducible CRY1 expression vector to obtain clear and
direct evidence for the buffering effect of PER on CRY using a
real-time Per2 transcription monitoring system (Figures 1E–
1H). This expression system facilitated the generation of a
time lag between PER2 and CRY1 expression. In the absence
of the IPTG-inducible CRY1 expression vector and indepen-
dently of the presence of PER2, IPTG treatment did not affect
the BMAL1-CLOCK-activated Per2 transcription (Figures 1E
and 1G). In contrast, in cells transfected with the IPTG-
inducible CRY1 expression vector, IPTG-induced CRY1 gradu-
ally repressed BMAL1-CLOCK-activated Per2 transcription
(Figure 1F), whereas CRY1-mediated transcriptional repression
was buffered significantly when PER2 was expressed prior to
CRY1 induction (Figure 1H). These data demonstrate the buff-
ering effect of PER on CRY function.
Specificities of PER-Mediated CRY Suppression
The buffering effect of PER2 on CRY1 was further examined in
the presence of overexpressed BMAL1-CLOCK or BMAL1-
NPAS2 complexes, as shown in Figure 2A. Under these condi-
tions, CRY1-induced transcriptional repression was inhibited
by the coexpression of PER2, which was completely dependent
on the physical interaction between CRY1 and PER2 via the
C-terminal region of PER2. These data show that PER2 had
equal effects on the BMAL1-CLOCK and BMAL1-NPAS2
complexes.
The BMAL1-CLOCK complex activates transcription of not
onlyPer but alsoCry. Therefore, we performed the same analysis
using the Cry1 or Cry2 promoter (Figure 2B). Although the effect
was not strong compared with the Per2 promoter, PER also
restored the CRY-mediated inhibition of transcription from the
Cry1 and Cry2 promoters. These results support the hypothesis
that PER2 buffers CRY1-mediated transcriptional repression.
PER1 and PER2, but not PER3, Protect Transcriptional
Activity from CRY
PER1 and PER2 have nonredundant roles in the mammalian
circadian clock (Bae et al., 2001; Zheng et al., 2001). We per-
formed similar experiments using PER1 to confirm the results
obtained with PER2 and to compare the effect of PER2 on
CRY1-mediated transcriptional repression with that of PER1.
First, we narrowed the CRY-binding domain using a deletion
series of PER1 constructs. The C-terminal domain of PER1 inter-
actedwith CRY,whichwas also the casewith PER2 (Figure S1A).
Next, we examined the effect of PER1 overexpression on the1058 Cell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authorsbasal transcriptional activity of Per2, which showed that PER1
mildly upregulated Per2 transcription, which was also the case
with PER2 (Figure S1B). As expected, the association of CRY1
with the C-terminal domain of PER1 was indispensable for this
upregulation effect. We also examined the neutralizing effect of
PER1 on CRY1-mediated transcriptional repression (Figure 2C).
PER1 expression neutralized CRY1-mediated repression at
doses similar to those of the PER2 expression plasmid, which
was completely dependent on CRY1 binding to the C-terminal
domain of PER1. Furthermore, similar experiments with CRY2-
mediated transcriptional repression showed that PER2 neutral-
izedCRY2more potently thanCRY1 (Figure 2D). Higher amounts
of PER2 than CRY1 were necessary for the protection against
CRY1-mediated transcriptional repression, whereas the neutral-
ization of CRY2-mediated repression was detectable even at
lower amounts of PER2 than CRY2. However, the relative
amount of PER1 required to effectively counteract CRY2 was
similar to that of CRY1. Overall, these results show that PER2
counteracts CRY2-mediated repression more effectively than
PER1, and both PER1 and PER2 exert anti-CRY1 functions in
a similar dose-dependent manner. These results confirm that
PER proteins have a protective effect against CRY-mediated
transcriptional repression, and demonstrate that target speci-
ficity in the PER-mediated neutralization of CRY may provide a
mechanism for the distinct and nonredundant roles of PER1
and PER2 proteins.
PER3 had no effects on the basal transcriptional activity of
Per2 or CRY1-mediated transcriptional repression (Figure 2E).
According to gene knockout studies (Bae et al., 2001; Shearman
et al., 2000), unlike PER1 and PER2, PER3 is considered to have
a minor role in the core clock and is a component required for
circadian outputs. However, all three PERmolecules have similar
transcriptional repressor activities (Kume et al., 1999); therefore,
the mechanism that underlies the functional differences among
these three PER molecules remains undefined. Our present re-
sults show that there is a distinct functional difference between
PER1/PER2 and PER3. Therefore, because PER3 does not
have the ability to counteract CRY-mediated transcriptional
repression, the role of PER3 in the core clock is distinct from
that of PER1/PER2.
The restoration of transcriptional activity may be caused by
the PER-induced subcellular translocation of CRY rather than
the PER-mediated direct silencing of CRY activity. It is well
known that overexpressed PER2 determines the intracellular
localization of CRY (Albrecht et al., 2007). To investigate the
effect of PER2-mediated translocation onCRY1 activity, we con-
structed expression vectors for PER2-NES and PER2-NLS
fusion proteins to perform signal sequence-driven translocation
of PER2. With increasing amounts of these expression vectors,
the subcellular localization of CRY1 changed via its physical
interaction with PER2 (Table S1). Nevertheless, all three PER2
molecules inhibited CRY1 activity to a similar extent (Figure 2F),
suggesting that the PER2-mediated inhibition of CRY1 is
independent of the subcellular localization of CRY. Thus, the
PER2-CRY1 complex is functionally silenced in the cytoplasm
and nucleus.
Our data might be dependent on mass action caused by
overexpression. We therefore investigated the stoichiometry
Figure 2. Target Specificity in PER-Mediated Neutralization of CRY
(A and B) Luciferase assay (NIH 3T3 cells).
(B) PER2-mediated fold restoration of Per2, Cry1, or Cry2 transcription, the activities of which were repressed by CRY1 or CRY2, respectively.
(C–F) Luciferase assay (NIH 3T3 cells).
(G) Left: purified PER2 and CRY2 proteins were stained with Coomassie brilliant blue (CBB) and Lumitein (a red fluorescent dye; Biotium), and used to obtain a
standard curve. Top right: livers were collected every 4 hr from Zeitgeber time 5 (ZT5) to ZT21, and nuclear and cytoplasmic fractions were subjected to western
blot analysis. The black and white arrowheads indicate CRY2 and nonspecific signals, respectively. CREB and tubulin were used as nuclear and cytoplasmic
markers, respectively. Bottom right: to examine the stoichiometry between the PER2 and CRY2 proteins, we used purified PER2 and CRY2 proteins to obtain a
standard curve. Western blot signals were calibrated using the standard, and the ratio between PER2 and CRY2 signals in the nucleus and cytoplasm of the
liver was semiquantitatively calculated. The reproducibility was confirmed by repeating independent experiments, and one set of representative data is
presented.
(H) Luciferase assay. Bottom: whole-cell extracts were subjected to western blot analysis with anti-PER2 and -CRY2 antibodies. As mentioned above, the ratio
between PER2 and CRY2 signals in luciferase assay samples was semiquantitatively calculated.
See also Figure S1 and Table S1.between PER and CRY where PER antagonized CRY. The
nuclear entry of endogenous CRY almost completely depends
on PER (Lee et al., 2001), indicating that nearly all nuclear CRY
forms a complex with PER. Thus, the ratio between nuclear
PER and CRY molecules should be near one. To examine
whether this prediction holds true for not only in vivo but also
overexpression-based assays, we focused on measuring the
PER2 and CRY2 ratio. The PER2-CRY2 complex seems physio-
logically more significant than other PER-CRY complexes, as
the buffering effect of PER2 on CRY2 is much higher than that
of other PER-CRY combinations. First, we semiquantitativelyCcompared the amount of endogenous nuclear PER2 with that
of CRY2 in the liver using purified PER2 and CRY2 as a standard
(Figure 2G). Our findings show that the nuclear concentration of
both proteins is within a similar range, as predicted. Next, we
examined whether this stoichiometry holds true when PER2 in-
hibits CRY2 in overexpression-based reporter assays (Fig-
ure 2H). The data indicate that similar amounts of PER and
CRY are needed to strongly cancel out the CRY-mediated inhib-
itory activity. The in vivo stoichiometry between PER2 and CRY2
is therefore consistent with that obtained in overexpression-
based assays.ell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authors 1059
Figure 3. The C-Terminal Fragment of PER2 Potently Counteracts CRY-Mediated Transcriptional Repression, and Attenuated Anti-CRY2
Activity May Be Responsible for the Loss of Function in the PER2brdm1 Protein
(A) COS7 cells were transfected with the indicated expression vectors, and whole-cell extracts were subjected to immunoprecipitation (IP; anti-MYC antibody).
Western blotting was performed with the indicated antibodies. Because the molecular weight of MYC-PER2 (1,157–1,257) is very low (10 kDa), detecting this
fragment via western blotting is technically difficult.
(B–D) Luciferase assay (B and D: NIH 3T3 cells; C: Cry-deficient MEFs).
(E and F) NIH 3T3 cells were transfected, and Per1 or AVP transcription was evaluated using a luciferase assay.
(G and H) Luciferase assay (NIH 3T3 cells). The western blotting data show PER2 and PER2brdm1 expression levels.
See also Figure S2.The C-Terminal Region of PER2 Contains a Domain
that Facilitates the Potent Protection of Transcription
from CRY
The C-terminal region of PER, including the CRY-binding
domain, must be essential for the PER-mediated protection of
transcription. Therefore, we performed further experiments to
investigate whether the C-terminal region alone is sufficient to
protect transcription. An expression vector was constructed
for the C-terminal region of PER2 (PER2 [1,068–1,257]). First,
the ability of this region to bind to CRY1 was examined in an
immunoprecipitation study (Figure 3A). Because the expression
level of PER2 (1,068–1,257) was similar to that of full-length
PER2, this C-terminal fragment physically interacted with
CRY1 more strongly than full-length PER2. This result suggests
the hypothesis that the C-terminal region, including the CRY-
binding domain, is masked in the full-length protein and the
accessibility to CRY1 is therefore limited.
Interestingly, PER2 (1,068–1,257) not only promoted Per2
transcription much more strongly than the full-length protein
(Figure 3B) but also resulted in a very potent inhibition of CRY-1060 Cell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authorsmediated transcriptional repression (Figure 3D). These effects
may have been dependent on the strong affinity between CRY
and the unmasked C-terminal region of PER, as shown in Fig-
ure 3A. Similar to what was observed for the full-length PER2,
the PER2 (1,068–1,257)-mediated activation of transcription
was dependent on endogenous CRYs, because the activation
was not detected in MEFs (Cry/; Figure 3C), thus indicating
that the transcriptional activation was caused mainly by the
PER2 (1,068–1,257)-mediated potent neutralization of endoge-
nous CRY function. On the other hand, PER2 (1,157–1,257)
with an incomplete CRY-binding domain had no obvious effect
on Per2 transcription.
The PER2brdm1 Protein Causes Dysfunctional Anti-CRY2
Activity
Although Per2brdm1 is considered a loss-of-function allele, it
remains unclear why the deletion of 87 amino acids causes func-
tional defects. First, we examined the differences in transcrip-
tional repression activity between the wild-type PER2 and
PER2brdm1 protein (Figures 3E and 3F). Because transcriptional
repression activity was not detectable with thePer2 promoter, as
shown in Figure 1A, we used Per1 and the Avp (arginine vaso-
pressin) promoter in the evaluation. The results showed that
although both proteins had a mild transcriptional repression
activity, an obvious difference between these two proteins was
not detectable.
Furthermore, we performed a comparison between the wild-
type PER2 and PER2brdm1 proteins on the basis of their phys-
ical affinities to BMAL1, CLOCK, CRY1, and CRY2 (Figure S2).
As shown in previous studies, PER2 is able to bind to all
of them (Langmesser et al., 2008). As expected, both PER2
proteins had similar affinities to CRY1 and CRY2, because
the C-terminal region of the mutant was intact. The deleted
region contained part of the PAS-B domain, but PER2brdm1
did not exhibit any defects in its ability to bind to BMAL1
and CLOCK (Figure S2A). The affinities were semiquantita-
tively confirmed, and the results show that the affinity of
PER2 to BMAL1-CLOCK is much lower than that to CRY
(Figure S2B). Importantly, a previous report demonstrated
that endogenous BMAL1-CLOCK does not bind to posttransla-
tionally unmodified PER (Lee et al., 2001), which is consistent
with our present findings because most PER exists in a post-
translationally unmodified form when overexpressed in cultured
cells. Thus, the binding of PER to BMAL1-CLOCK observed in
Figure S2A might be physiologically insignificant, suggesting
that the PER-CRY complex does not bind to the BMAL1-
CLOCK complex when posttranslationally unmodified PER
inhibits CRY.
Next, we examined the difference between the wild-type
PER2 and PER2brdm1 on the basis of their abilities to suppress
CRY-induced transcriptional repression (Figures 3G and 3H).
Interestingly, both of the PER proteins had a similar neutralizing
effect on CRY1, whereas PER2brdm1 had a severely reduced
effect on CRY2. The data obtained in the present study suggest
that the reduced anti-CRY2 activity of PER2brdm1 provides
a mechanistic explanation for the loss of function with the
Per2brdm1 allele.
Consistent with numerous previous reports, PER2 exerted a
low inhibitory activity on the Per1 promoter (Figure 3E) and
moderately repressed the transcriptional activity of the AVP pro-
moter (Figure 3F), although we needed to use a much higher
amount of a PER2 expression vector (100 ng) than when
PER2 activated Per2 transcription (10 ng), as shown in our
findings. PER2 could not inhibit the Per2 promoter at all, and
instead activated it via inhibition of CRY, indicating that PER2
may play different roles in a promoter-specific manner. For
further validation of the promoter-specific effect of PER2,
we investigated the change in expression levels of BMAL1-
CLOCK-controlled genes (output genes) in Per2-deficient mice
(Table S2). We used two data sets: one from a comprehensive
analysis of gene-expression levels in Per2-deficient mice (Gri-
maldi et al., 2010), and one including genes whose expression
is under the direct control of BMAL1-CLOCK (Koike et al.,
2012). We extracted genes common to both data sets, and
the results demonstrate that expression is upregulated in
some genes but downregulated in others, supporting the
idea that PER2 may play different roles in a promoter-specific
manner.CPER Blocks CRY Recruitment into the BMAL1-CLOCK
Complex
Next, we investigated the formation of the clock protein complex
on an E-box consensus sequence, using a purified protein assay
system to elucidate the mechanism by which PER protects tran-
scription from CRY. To exclude the possibility that the BMAL1 or
CLOCK monomer is structurally unstable, BMAL1 and CLOCK
were coexpressed in HEK293A cells and purified as a dimer (Fig-
ure 4A). CLOCK expression levels were much lower than BMAL1
expression levels, and a considerable proportion of BMAL1 was
immunoprecipitated as a monomer when an antibody against
BMAL1 was used. To reduce monomer contamination, we
purified BMAL1-saturated CLOCK using an antibody against
CLOCK. The purified BMAL1-CLOCK complex was incubated
with a probe containing an E-box sequence, which was applied
to nondenaturing polyacrylamide gels (Figure 4B). We confirmed
that the electrophoretic mobility of the probe was shifted by the
physical interaction with BMAL1-CLOCK. Antibodies against
each protein were used to validate that the BMAL1-CLOCK-
bound probe was supershifted. As expected, CRY did not bind
directly to the probe independently of or together with PER.
Moreover, we confirmed CRY recruitment into the BMAL1-
CLOCK-bound E-box in an electrophoretic mobility shift assay
(EMSA) (Figure 4C). Incubation of the BMAL1-CLOCK-bound
probewith purified CRY1 caused an additional slight electropho-
retic mobility shift of the probe. We found that incubation with an
antibody against purified CRY1was highly effective at enhancing
the mobility shift. In the experiments described below, we used
the same assay procedure to evaluate the effect of PER on
CRY recruitment into the BMAL1-CLOCK complex.
To investigatewhetherPER inhibitedCRY1 recruitment,wepu-
rified PER proteins using a method similar to that described for
BMAL1-CLOCK purification (Figure 4D). Because PER may be
structurally unstable as a monomer, especially in the PER2 dele-
tion mutant proteins, we purified PER as a complex with CRY by
immunoprecipitationusinganantibodyagainstCRY.PER2DCBD
severely lacked any affinity to CRY1, and the amount of the puri-
fied protein was therefore greatly reduced when it was coimmu-
noprecipitated with CRY1. In an EMSA experiment, we found
that PER2 interfered with CRY recruitment into the BMAL1-
CLOCKcomplex, as expected (Figure 4E).When a higher amount
of CRY1-PER2 was added, CRY1was recruited into the BMAL1-
CLOCK complex, suggesting two possibilities: (1) a fraction of
CRY1 was purified as the PER2-unbound monomer, which
caused the mobility shift of the probe as the concentration
increased, or (2) the BMAL1-CLOCK complex associated kineti-
cally with CRY1 in competition with PER2, and CRY1-BMAL1-
CLOCK increased with the CRY1-PER2 concentration. Interest-
ingly, PER3 did not interfere with CRY1 recruitment, and this
was also explained by PER3’s dispensability as a component of
the clock machinery on the basis of in vivo phenotypic analyses.
Next, we performed the same EMSA experiment using PER2
mutant proteins. PER2DCBD did not affect the formation of the
CRY1-BMAL1-CLOCK complex on the probe. As expected,
PER2 (1,068–1,257), the CRY-binding domain, inhibited CRY1
recruitment. Unlike the full-length PER2 protein, CRY1 recruit-
ment was blocked almost completely, even in the presence of
a higher amount of CRY1-PER2 (1,068–1,257). As shown inell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authors 1061
Figure 4. PER Interferes with CRY Recruitment into the BMAL1-CLOCK Complex
(A) Silver staining of SDS-PAGE gels. HEK293A cells were cotransfected and the BMAL1-CLOCK complex was purified with anti-FLAG antibody-conjugated
agarose beads. The brackets show the purified CLOCK and BMAL1 proteins. The asterisk shows a nonspecific contaminant.
(B) EMSA. A 32P-labeled double-stranded oligonucleotide that contained an E-box consensus sequence was used as a probe. The BMAL1-CLOCK-bound probe
is indicated with an arrowed line. The brackets show that the BMAL1-CLOCK-bound probe was supershifted by the addition of antibodies. The free probe is
indicated with an open arrowhead.
(C) EMSA. The same probe was incubated with BMAL1-CLOCK in the presence or absence of FLAG-CRY1. The dashed line indicates the leading edge of the
BMAL1-CLOCK-bound probe.
(D) Silver staining of SDS-PAGE gels. HEK293A cells were cotransfected with the indicated plasmids, and PER-bound FLAG-CRY1 was purified with anti-FLAG
antibody-conjugated agarose beads.
(E and F) EMSA. The same probe was incubated with BMAL1-CLOCK, and FLAG-CRY1 or PER-bound FLAG-CRY1was added. All samples were incubated with
an anti-FLAG antibody to detect CRY1 recruitment into the BMAL1-CLOCK-bound probe. The open arrowhead shows the BMAL1-CLOCK-bound probe. The
filled arrowhead shows the CRY1-BMAL1-CLOCK-bound probe. The amount of FLAG-CRY1 used was confirmed by western blotting (bottom column).
(G) A schematic model of the PER-mediated time delay during circadian transcriptional repression. Previous in vivo reports suggested that the amount of CRY is
much higher than that of PER, while PER is essential for the nuclear entry of CRY (Lee et al., 2001), which indicates that nuclear CRY is saturated with PER. PER-
bound CRY does not produce immediate potent transcriptional repression because of the PER-induced silencing effect. The PER-mediated neutralization of CRY
causes a time delay in CRY-mediated transcriptional repression, which may help to extend the transcriptional oscillation period.
See also Table S2.Figure 3A, PER2 (1,068–1,257) bound to CRY1 more strongly
than the full-length PER2 protein, which may be the mechanism
that underlies the results obtained in the EMSA experiment, as
well as the luciferase assay data. In agreement with the results
of the luciferase assay shown in Figure 3, PER2brdm1 had almost
the same effect on CRY1 recruitment as the full-length PER2.
Because the anti-CRY2 activity of the mutant protein was
remarkably decreased, as shown in the luciferase assay
described above, we attempted to perform an EMSA experiment
using purified CRY2. However, the purified protein appeared to1062 Cell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authorsbe nonfunctional in vitro, and thus we were unable to perform
the assay. Overall, the purified protein-based assays showed
that the molecular mechanism that allows PER to protect tran-
scription from CRY might be PER-induced interference with
CRY recruitment into the BMAL1-CLOCK complex.
DISCUSSION
In vivo phenotypic approaches are necessary but insufficient
for obtaining a thorough understanding of the functions of
clock components at the molecular level, and detailed in vitro
analyses can therefore provide powerful support for in vivo
phenotypic evidence. In the case of PER, however, although
the in vivo phenotypic data obtained mainly from knockout
mice have provided definitive proof that PER is an essential
component of the clock machinery, in vitro functional analyses
have not fully elucidated the indispensable roles of PER. Our
present results support the hypothesis that PER might function
as a buffer in CRY-mediated transcriptional repression, and
Figure 4G shows the significance of our findings in the circadian
gene-expression model. According to previous reports, the
nuclear entry of CRY is almost completely dependent on
PER, indicating that all of the endogenous nuclear CRY proteins
form a complex with PER (Lee et al., 2001). If the nuclear PER-
CRY complex were to act immediately as a potent negative
regulator against the BMAL1-CLOCK complex, it would be diffi-
cult to generate a circadian period in the transcriptional
negative feedback loop. The present study shows that the
PER-CRY negative regulatory complex might be temporally in-
activated in the nuclei, thereby leading to a time delay in the
feedback machinery. Consistent with this interpretation, nu-
merous observations have indicated that levels of Per2 mRNA
remain high even during the phase in which the PER-CRY com-
plex highly accumulates in the nucleus, indicating that the
complex is not fully active as a transcriptional repressor. Sub-
sequently, the PER-CRY complex would become active as a
transcriptional repressor via an unknown factor(s) or simply by
a gradual increase in the PER-CRY concentration in nuclei.
This buffering effect of PER may play a role in generating the
stable and long-duration transcriptional feedback.
Interestingly, the function of PER identified in the present
study appears to be highly consistent with previous in vivo
phenotypic data obtained using mainly knockout mice. Indeed,
the phenotypes observed in Per2brdm1 mutant mice and Per-
deficient mice are supported by the in vitro functional data
obtained in the present study. The PER2brdm1 protein lacks 87
amino acids that overlap with part of the PAS-B domain.
Phenotypic analyses have suggested that PER2brdm1 is a
loss-of-function protein, but in vitro functional analyses have
not provided evidence for the mechanism by which the deletion
causes functional defects. We confirmed that there was little
difference between the wild-type PER2 and PER2brdm1 proteins
in terms of their transcriptional repression activities. In contrast,
we found that the PER2brdm1 protein severely lacked a buffering
effect on CRY2 activity, which might be the mechanism that
underlies the loss of function observed with the PER2brdm1
protein. The PER1 protein has a redundant role with PER2 in
anti-CRY1 activity, but not in anti-CRY2 activity, as shown in
Figure 2D. However, further studies are required to elucidate
why the Per2brdm1 mutation causes a defect only in anti-
CRY2 activity and not in anti-CRY1 activity, and how the mutant
protein causes the functional defect despite the existence of an
intact CRY-binding domain. In addition to this mechanistic
issue, another possible explanation for the Per2brdm1 phenotype
is that the PER2brdm1 protein is simply less stable or its transla-
tion efficiency is lower than that of wild-type PER2 in vivo. In the
overexpression experiments shown here, it is difficult to inves-
tigate these possibilities, and thus our data cannot lead to aCdefinitive conclusion about why this mutation results in loss of
function.
Importantly, the relationships between the types of PER mol-
ecules and the patterns of protection against CRY are highly
consistent with previous studies of Per knockout mice. First,
PER3 had no protective effect on transcription, which is consis-
tent with the fact that the clock functions normally in Per3
knockout mice (Bae et al., 2001; Shearman et al., 2000). Second,
although PER1 and PER2 have a similar protective effect against
CRY1-mediated transcriptional repression, PER2 provides more
potent protection of transcription from CRY2 than PER1. Thus,
PER2 could overcome the loss of PER1-mediated anti-CRY
activity. This indicates that PER2 has a more essential role in
the core clock, which is also consistent with animal studies in
which Per2 knockout caused more severe circadian dysfunc-
tions than Per1 knockout (Bae et al., 2001; Zheng et al., 2001).
Furthermore, an interesting report showed that Cry2 disruption
restored circadian rhythmicity in Per2 mutant mice (Oster
et al., 2002). The present study results may explain themolecular
mechanism in the following manner: PER2 strongly buffers
CRY2-mediated transcriptional repression, and circadian gene
expression is disrupted by an excess of free CRY2 in Per2
mutantmice.Cry2 inactivation inPer2mutantmicemay reinstate
the quantitative balance between PER and CRY proteins, sug-
gesting that this could be the restorative mechanism in Per2/
Cry2 double-knockout mice.
PER might have a bimodal function. First, previous reports
have shown that, in addition to its low activity as a transcriptional
repressor, PER has an indispensable role in the nuclear entry of
CRY, which suggests that PER is involved in the negative limb in
the circadian transcriptional feedback loop. Second, we ob-
tained in vitro evidence that PER could protect transcription
from CRY via the physical interaction of PER with CRY, suggest-
ing that PER functions as a buffer that decelerates the transcrip-
tional repression process. Thus, PER could be classified as a
modulator rather than a component of the negative limb. Future
studies will be required to reveal how PER exerts promoter- and
phase-specific roles in vivo.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
In this study, NIH 3T3 fibroblasts were used in all of the cell-culture-based
assays, except that COS7 or HEK293A were used in special cases that
required relatively high levels of protein expression. NIH 3T3 cells are a well-
used cell line and are known to contain a functional, cell-autonomous circadian
clock system (Akashi and Nishida, 2000). Cells were grown in Dulbecco’s
modified Eagle’smedium (supplementedwith antibiotics and 10% fetal bovine
serum) and cultured in 5% CO2. Transfection of plasmid DNA into cells was
performed with Lipofectamine PLUS (Invitrogen) as described previously
(Akashi et al., 2002).
EMSA
The binding buffer contained 15 mM Tris-HCl (pH 7.5), 15 mM NaCl, 1.5 mM
EDTA, 1.5 mM dithiothreitol, 7.5% glycerol, 0.3% NP-40, and 1 mg/ml BSA.
The radiolabeled probe was added at 0.5 nM, and the purified clock proteins
were mixed and incubated for 10 min. Finally, the antibodies were added to
perform supershift experiments. All of the reactions were incubated at 25C.
The reactions were loaded onto 4% nondenaturing polyacrylamide gels and
resolved at 150 V for 2 hr at 4C. The gels were dried and exposed to an
X-ray film.ell Reports 7, 1056–1064, May 22, 2014 ª2014 The Authors 1063
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